Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
Options for Containing the Cost of a New Medicare Dental, Hearing, and Vision Benefit
USC-Brookings Schaeffer Initiative for Health Policy expert Matthew Fiedler analyzes options for reducing the cost of adding dental, hearing and vision coverage to Medicare.
-
Do Medicare’s Facility Fees Incentivize Hospitals to Vertically Integrate with Oncologists?
A new paper examining whether or not hospitals strategically choose to vertically integrate with clinical oncologists in order to capture facility fees, a commonly cited reason for increased consolidation in the healthcare market.
Posted in -
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members
A new Schaeffer Center study comparing Medicare Part D prescription drug prices with those paid by Costco members finds that the federal government overpaid on roughly half of the most common generic medicines in 2018.
Posted in -
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Access to the 340B Drug Pricing Program: Is There Evidence of Strategic Hospital Behavior?
Some hospitals adjust their measure that identifies hospitals that treat a disproportionate share of low-income patients to gain 340B eligibility.
Categorized in -
Assessing the Quality of SK&A’s Office-Based Physician Database for Identifying Oncologists
Schaeffer experts assess the quality of one of the most commonly used commercial databases, SK&A’s office-based physician database.
Categorized in -
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years.
Categorized in -
The Effects of Vertically Integrated Care on Health Care Use and Outcomes in Inpatient Rehabilitation Facilities
Receiving vertically integrated care in hospital-based inpatient rehabilitation facilities shortens institutional length of stay while maintaining or improving health outcomes.
Categorized in -
Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
Research from Schaeffer Center experts Darius Lakdawalla and Meng Li in JAMA Network Open finds U.S. insurers could use drug manufacturer rebates to lower retail pharmacy prices and reduce patient out-of-pocket burden by 38% on average, or 70% in the most competitive drug classes.
Categorized in -
Advance Care Planning for Medicare Beneficiaries Increased Substantially, but Prevalence Remained Low
Researchers examined fee-for-service Medicare claims and found a substantial increase in outpatient advance care planning claims between 2016 and 2019, although prevalence remained below 7.5 percent for all patient subgroups analyzed.
Categorized in